Endotoxin and cytokine release in strangulation obstruction and in partial occlusion of the mesenteric artery in pigs

European Surgical Research

Volumn 31, Issue 1, 1999, Pages 26-38

  Fevang, J ^a,b   OVrebo K ^a   Svanes, K ^a   Rokke O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokines; Endotoxin; Interleukin 1; Interleukin 6; Strangulation obstruction; Tumor necrosis factor

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BLOOD FLOW; ARTERY CLAMP; ARTERY OCCLUSION; ARTICLE; BLOOD FLOWMETRY; ILEUM; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; VENOUS PRESSURE;

EID: 0033032140     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008618     Document Type: Article

References (36)

1. Pullicino EA, Carli F, Poole S, Rafferty B, Malik ST, Elia M: The relationship between the circulating concentations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res 1990;9:231-238.
2. Guo Y, Dickerson C, Chrest FJ, Adler WH, Munster AM, Winchurch RA: Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 1990; 54:361-371.
3. Ueyama M, Maruyama I, Osame M, Sawada Y: Marked increase in plasma interleukin-6 in burn patients (see comments). J Lab Clin Med 1992;120:693-698.
4. Jones SC, Trejdosiewicz LK, Banks RE, Howdle PD, Axon AT, Dixon MF, Whicher JT: Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol 1993;46:1097-1100.
5. Michalsky MP, Deitch EA, Ding J, Lu Q, Huang Q: Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli. Shock 1997;7:137-146.
6. Gislason H, Rokke O, Svanes K: Release of cytokines associated with gastric mucosal injury. Eur Surg Res 1996;28:278-286.
7. Roscher R, Oettinger W, Beger HG: Bacterial microflora, endogenous endotoxin, and prostaglandins in small bowel obstruction. Am J Surg 1988;155:348-355.
8. Hicks C, Baumann FG, Enquist IF: Changes in intestinal flora in dogs with nonstrangulating intestinal obstruction. Surgery 1969;66:580-583.
9. Bishop RF, Allcock EA: Bacterial flora of the small intestine in acute intestinal obstruction. Br Med J 1960;12:766-770.
10. Sykes PA, Boulter KH, Schofield PF: The microflora of the obstructed bowel. Br J Surg 1976;63:721-725.
11. Gaffin SL, Gathiram P, Wells MT, Brock Utne JG: Effect of corticosteroid prophylaxis on lipopolysaccharide levels associated with intestinal ischemia in cats. Crit Care Med 1986;14:889-891.
12. Moore JN, White NA, Berg JN, Trim CM, Garner HE: Endotoxemia following experimental intestinal strangulation obstruction in ponies. Can J Comp Med 1981;45: 330-332.
13. Young NS, Levin J, Prendergast RA: An invertebrate coagulation system activated by endotoxin: Evidence for enzymatic mediation. J Clin Invest 1972;51:1790-1797.
14. Friberger Å, Knos M, Mellstam L: A quantitative endotoxin assay utilising Limulus lysate and a chromogenic peptide substrate; in Anonymous: Endotoxins and Their Detection with the Limulus Amebocyte Lysate Test. New York, Liss, 1982, pp 195-206.
15. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
16. Espevik T, Nissen Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
17. Rökke O, Rasmussen LT, Giercksky KE, Seljelid R, Rekvig OP, Revhaug A: The influence of plasma exchange on shock mediators in septicemia. Surg Res Comm 1990;8:173-182.
18. Gearing AJ, Bird CR, Bristow A, Poole S, Thorpe R: A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods 1987;99:7-11.
19. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: The types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
20. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17: 1411-1416.
21. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN: Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg 1970;101:478-482.
22. Satterhwaite FE: An approximate distribution of estimates of variance components. Biom Bull 1946;2: 110-114.
23. Winer BJ: Multifactor experiments having repeated measures on the same elements; in Maytham W, Shapiro A, Stern J (eds): Statistical Principles in Experimental Design. New York, McGraw-Hill, 1971, pp 514-603.
24. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 1996;224:647-664.
25. Ala Y, Palluy O, Favero J, Bonne C, Modal G, Dornand J: Hypoxia/ reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agents Actions 1992;37:134-139.
26. Cicco NA, Lindemann A, Content J, Vandenbussche P, Lubbert M, Gauss J, Mertelsmann R, Herrmann F: Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood 1990;75:2049-2052.
27. Meyer TA, Noguchi Y, Ogle CK, Tiao G, Wang JJ, Fischer JE, Hasselgren PO: Endotoxin stimulates interleukin-6 production in intestinal epithelial cells. A synergistic effect with prostaglandin E2. Arch Surg 1994;129:1290-1294.
28. Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Van Snick J: Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987;165:914-919.
29. Shenkin A, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJ, Van Damme J: The serum interleukin 6 response to elective surgery. Lymphokine Res 1989; 8:123-127.
30. Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Colch) 1990;79:161-165.
31. Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T: Interleukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992;111:201-209.
32. Helle M, Brakenhoff JP, De Groot ER, Aarden LA: Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 1988;18: 957-959.
33. Sheng ZY, Dong YL, Wang XH: Bacterial translocation and multiple system organ failure in bowel ischemia and reperfusion. Chin Med J (Engl) 1991;104:897-903.
34. Deitch EA: Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989;124; 699-701.
35. Jacob AI, Goldberg PK, Bloom N, Degenshein GA, Kozinn PJ: Endotoxin and bacteria in portal blood. Gastroenterology 1977;72:1268-1270.
36. Prytz H, Holst Christensen J, Korner B, Liehr H: Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis. Scand J Gastroenterol 1976; 11:857-863.